Press Releases
May 22, 2024
Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)
April 26, 2024
The UAE MOHAP Approves the First and Only Therapy for the Treatment of Adult Generalized Pustular Psoriasis Flares
April 25, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Media Contacts
Media Contact - Corporate Affairs
Manager, Human Pharma Communications, IMETA, Corporate Affairs
Phone+971 55 957 6046
Mobile+971 55 957 6046
Media Contact - Corporate Affairs
Manager, Human Pharma and Animal Health Communications, IMETA, Corporate Affairs
E-Mail : feda.kassem@boehringer-ingelheim.com
Current Events
Past Events
Event
Annual Results Press Conference 2022
